Pfizer (PFE) Said to Plan IPO of Animal-Health Unit in Early FY13
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Price: $25.63 -2.44%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 6.6%
EPS Growth %: -58.5%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 6.6%
EPS Growth %: -58.5%
Join SI Premium – FREE
Pfizer (NYSE: PFE) shares are ticking higher in late trading Thursday, amid new talk surrounding the IPO of Zoetis.
According to the WSJ, Pfizer is planning to take Zoetis -- Pfizer's animal0-health unit -- public in January or February 2013. The IPO is expected to price somewhere around $4 billion.
Pfizer is running low on options for Zoetis; its $20 billion valuation is priced out of many potential buyers range. Pfizer attempted to divest the unit last year, saying animal-heath products didn't gel with its human-health focus.
Shares are modestly higher after hours.
According to the WSJ, Pfizer is planning to take Zoetis -- Pfizer's animal0-health unit -- public in January or February 2013. The IPO is expected to price somewhere around $4 billion.
Pfizer is running low on options for Zoetis; its $20 billion valuation is priced out of many potential buyers range. Pfizer attempted to divest the unit last year, saying animal-heath products didn't gel with its human-health focus.
Shares are modestly higher after hours.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer Declares Second-Quarter 2024 Dividend
- Rubrik (RBRK) Prices 23M Share IPO at $32/sh, Above Indicated $28-$31/sh Range - Reuters
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
Create E-mail Alert Related Categories
IPOs, Rumors, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
